Your browser doesn't support javascript.
loading
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Komen, Joris J; Pottegård, Anton; Mantel-Teeuwisse, Aukje K; Forslund, Tomas; Hjemdahl, Paul; Wettermark, Björn; Hellfritzsch, Maja; Hallas, Jesper; Olesen, Morten; Bennie, Marion; Mueller, Tanja; Voss, Annemarie; Schink, Tania; Haug, Ulrike; Kollhorst, Bianca; Karlstad, Øystein; Kjerpeseth, Lars J; Klungel, Olaf H.
Affiliation
  • Komen JJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Pottegård A; Department of Healthcare Development, Stockholm Region, Public Healthcare Services Committee, Stockholm, Sweden.
  • Mantel-Teeuwisse AK; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Forslund T; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Hjemdahl P; Department of Healthcare Development, Stockholm Region, Public Healthcare Services Committee, Stockholm, Sweden.
  • Wettermark B; Department of Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Hellfritzsch M; Department of Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Hallas J; Department of Pharmacy, Pharmacoepidemiology & Social Pharmacy, Uppsala University, Uppsala, Sweden.
  • Olesen M; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Bennie M; Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
  • Mueller T; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Voss A; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Schink T; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Haug U; Public Health and Intelligence Strategic Business Unit, NHS National Services Scotland, Glasgow, UK.
  • Kollhorst B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Karlstad Ø; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
  • Kjerpeseth LJ; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
  • Klungel OH; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Europace ; 23(11): 1722-1730, 2021 11 08.
Article in En | MEDLINE | ID: mdl-34096584
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2021 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2021 Type: Article Affiliation country: Netherlands